Ji Yanzhao, You Yanting, Wu Yifen, Wang Min, He Qiuxing, Zhou Xinghong, Chen Liqian, Sun Xiaomin, Liu Yanyan, Fu Xiuqiong, Kwan Hiu Yee, Zuo Qiang, Luo Ren, Zhao Xiaoshan
Syndrome Laboratory of Integrated of Chinese and Western Medicine, School of Chinese Medicine, Southern Medical University, Guangzhou, China.
Department of Nephrology, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Taiyuan, China.
Ann Transl Med. 2022 Mar;10(6):301. doi: 10.21037/atm-22-345.
Lung cancer is the leading cause of cancer-associated mortality worldwide, and most lung cancers are classified as non-small cell lung cancer (NSCLC). MiR-328 influence the progression of multiple tumors, but the role of miR-328-5p in NSCLC has not been elucidated. The aim of this study was to illuminate the oncogenic role and potential molecular mechanisms of the miR-328-5p and lysyl oxidase like 4 (LOXL4) in NSCLC.
Expression of miR-328-5p was detected by real-time quantitative polymerase chain reaction (qRT-PCR) in tumor and non-tumor adjacent tissues. After Lentivirus-miR-328-5p was employed to intervene this miRNA in NSCLC cell lines, RT-qPCR was used to detect the expression levels of miR-328-5p. Cell Counting Kit-8 (CCK-8), cell colony formation, flow cytometry, wound healing, Transwell assays were used to determine the malignant phenotypes of NSCLC cells. Nude mice models of subcutaneous tumors were established to observe the effect of miR-328-5p on tumorigenesis. Targeting the 3'UTR of LOXL4 by miR-328-5p was verified by integrated analysis including transcriptome sequencing, dual-luciferase and western-blot assays.
High miR-328-5p level was observed in NSCLC cells from The Cancer Genome Atlas (TCGA) database and tumor tissues collected from NSCLC patients. Overexpressed miR-328-5p promoted NSCLC cell proliferation, survival, and migration, and promoted tumor growth . Knockdown of miR-328-5p suppressed tumorigenic activities. Transcriptome sequencing analysis revealed that LOXL4 was downregulated by miR-328-5p, which was confirmed by dual-luciferase reporter and western-blot assays.
miR-328-5p showed targeted regulation of LOXL4 to promote cell proliferation and migration in NSCLC.
肺癌是全球癌症相关死亡的主要原因,大多数肺癌被归类为非小细胞肺癌(NSCLC)。MiR-328影响多种肿瘤的进展,但miR-328-5p在NSCLC中的作用尚未阐明。本研究的目的是阐明miR-328-5p和赖氨酰氧化酶样4(LOXL4)在NSCLC中的致癌作用及潜在分子机制。
通过实时定量聚合酶链反应(qRT-PCR)检测肿瘤组织和非肿瘤相邻组织中miR-328-5p的表达。在NSCLC细胞系中使用慢病毒-miR-328-5p干预该miRNA后,用RT-qPCR检测miR-328-5p的表达水平。使用细胞计数试剂盒-8(CCK-8)、细胞集落形成、流式细胞术、伤口愈合、Transwell实验来确定NSCLC细胞的恶性表型。建立皮下肿瘤裸鼠模型以观察miR-328-5p对肿瘤发生的影响。通过包括转录组测序、双荧光素酶和蛋白质免疫印迹分析在内的综合分析验证miR-328-5p对LOXL4 3'UTR的靶向作用。
在癌症基因组图谱(TCGA)数据库中的NSCLC细胞以及从NSCLC患者收集的肿瘤组织中观察到高miR-328-5p水平。过表达的miR-328-5p促进NSCLC细胞增殖、存活和迁移,并促进肿瘤生长。敲低miR-328-5p可抑制致瘤活性。转录组测序分析显示LOXL4被miR-328-5p下调,这通过双荧光素酶报告基因和蛋白质免疫印迹分析得到证实。
miR-328-5p显示出对LOXL4的靶向调控,以促进NSCLC中的细胞增殖和迁移。